Neural Regeneration Research,
Journal Year:
2021,
Volume and Issue:
17(1), P. 103 - 103
Published: June 11, 2021
The
complex
and
mostly
multiple
unknown
aetiology
of
neurodegenerative
diseases
always
give
way
to
an
intricate
scenario
dying
tissue
that
involves
cell
mediators
types.
All
the
central
nervous
system
(CNS)
share
common
mechanisms,
regardless
their
origin:
oxidative
stress,
neuroinflammation
death.
Accordingly,
retinal
degenerative
diseases,
with
or
without
a
genetic
cause,
as
retinitis
pigmentosa
(RP),
glaucoma,
age-related
macular
degeneration
(AMD)
diabetic
retinopathy
(DR)
do
not
differ
in
basic
mechanisms
death
neither
one
another,
nor
from
those
observed
other
CNS
Parkinson's
Alzheimer's
(Cuenca
et
al.,
2014).
Indeed,
therapeutic
findings
should
be
able
more
less
easily
extrapolated
between
these
conditions,
far
they
are
directed
dartboards.
Gene
therapy,
which
we
have
very
high
hopes
solve
disorders,
is
currently
being
traslated
preclinical
assays
clinic
for
some
successful
achievement
up
today
Leber
congenital
amaurosis,
due
mutations
RPE65
gene
(Garafalo
2020).
But
our
promising
therapies
still
face
relevant
challenges.
In
this
sense,
CRISP/Cas
editing
tools
used
amend
missenses,
need
fix
secondary
effects,
related
immune
response
(Yu
2017);
stem
approaches
procure
functionality
transplanted
cells
recipient,
assure
accurate
establishment
synaptic
connectivity
contacts,
gain
success
precise
image
processing
(Cuevas
2019;
Garita-Hernandez
2019);
optogenetics
also
needs
find
appropriate
vectors
delivery
expression
suitable
types,
avoiding
immunological
rejection
vector
systems
(Shen
While
gene-
cell-based
evolve
through
tortuous
pathway
biological
success,
combined
antioxidant
(as
lutein
zeaxanthin),
antiinflammatory
corticosteroids
cannabinoids),
antiapoptotic
tauroursodeoxycholic
acid
proinsulin)
molecules
appear
widest
approach
pharmacologically
treat
wide
spectrum
diseases.
These
compounds
provide
several
advantages.
They
can
slow
down
progression
process,
so
preserving
visual
capacity
certain
time.
Moreover,
administration
neuroprotective
factors
essential
even
when
vision
has
been
completely
lost,
improve
non-visual
functions,
like
control
circadian
rhythms
pupil
contraction,
cannabinoid-mediated
improvement
rhythmicity
P23H
rats,
mediated
by
melanopsin-containing
photosensitive
ganglion
(Lax
2019).
Non-visual
functions
effects
on
memory
depression.
Therefore,
preservation
subset
cells,
although
will
function,
surely
quality
life
patients
underestimated.
But,
beyond,
increase
new
therapies,
adequate
environment
healthy
substrate
transplant
optogenetic
approaches,
could
hardly
damaged
surrounded
cells.
Genetic
material
potentially
incorporated
retina
eventually
restore
zone
it
injected
but,
global
actuation
whole
maintaining
health
adjacent
inflamed
surrounding
end
complete
failure
any
therapy.
Hence,
concomitant
use
antiinflammatory,
agents,
well
neurotrophic
growth
factors,
help
achieve
sustained
functional
restoration
function
(Figure
1),
shown
combination
progesterone
lipoic
mouse
model
RP
(Ramirez-Lamelas
2018).Figure
1:
antioxidant,
contributes
neuroprotection.Retinal
neuroprotection
cell-
gene-based
treatment
counteract
inflammation
processes,
all
them,
whichever
origin
is.Concerning
antioxidants,
quite
experimental
evidence
vivo
models
points
stress
modulate
Photoreceptor
metabolic
rate,
accumulation
mitochondria
great
consumers
oxygen.
An
overproduction
reactive
oxygen
species
(ROS)
and/or
reduced
ability
neutralize
increases
leading
oxidization
inhibition
phosphatases,
kinases
proteins,
alteration
downstream
signaling
pathways,
triggering
apoptosis
antioxidants
good
results
different
proven
preserve
both,
animal
patients.
Also,
obtained
dietary
supplementation
vitamin
A,
zinc,
manganese,
curcumin,
saffron,
safranal,
ubiquinone
coenzyme
Q,
small
drugs
reduce
ROS
formation
(Fernandez-Sanchez
2015;
Newton
Megaw,
lipidic
omega-3
long-chain
polyunsaturated
fatty
acids,
docosahexaenoic
eicosapentaenoic
acid,
properties,
evaluating
AMD,
DR
(ClinicalTrials.gov).
Among
quantity
increasing
suggests
potential
benefits
but
clinical
trials
date
too
heterogeneous
molecules,
doses
results,
studies
needed
establish
safety
efficacy,
including
performance
long-term
assays.
toxicity
present
disorders
inflammatory
cytokines,
chemokines,
trophic
secreted
first
activated
microglia,
later
macroglia,
astrocytes
Müller
perpetuate
response,
either
worsening
process
Thus,
RP,
non-inherited
associated
chronic
microglial
activation
neuroinflammation.
degenerating
retinas,
change
"resting"
state,
secrete
into
form
migrating
amoeboid
show
variety
phenotypes,
increased
phagocytic
activity,
engulf
pathological
pro-inflammatory
ROS,
nitric
oxide
tumor
necrosis
factor-α,
promote
inflammation,
severe
side
what
result
irreversible
neuronal
(reviewed
2014)).
neurological
such
sclerosis,
attenuation
protective
effect.
regulation
minocycline
appears
approximation
under
evaluation
DR.
Another
block
inflammatory/death
processes
pharmacological
key
cellular
pathways
mammalian
target
rapamycin
glycogen
synthase
kinase-3.
proteins
regulatory
role
2019),
them
evaluation,
selective
inhibitor,
AMD
Promising
both
vitro
compounds,
most
showing
further
properties.
This
case
urso-
(Boatright
2009),
synthetic
progestin
norgestrel
proinsulin
2014;
Fernandez-Sanchez
2015).
Several
evaluated
bile
acids
specific
lacking.
Although
considered
predominant
mechanism
autophagy,
necroptosis,
pyroptosis
parthanatos
contribute
(Newton
We
know
necroptosis
autophagy
roles
Alzheimer´s
Parkinson´s
therapeutics
remains
seen.
For
exposed,
taking
account
involved
degeneration,
at
present,
best
chance
minimize
seems
apply
strategy,
than
compound
oxidant,
apoptotic
chemical
design
hybrid
motifs
addressed
targets,
modes
action
maintain
status.
Nowadays,
development,
its
efficiency
seen
next
years.
Besides,
prospective
greatly
influenced
development
ocular
long
lasting
frequencies.
Minimally
invasive
procedures
carry
agents
retina.
eye
drops
rare
chance,
formulations
tested
trials,
nerve
factor
glaucoma.
Other
small-interfering
RNAs,
administered
initially
intravitreal
injection
AMD),
topically
low
size,
carriers
development.
antibodies
(tested
DR)
designed
ankyrin
repeat
(for
(with
cross
many
barriers)
systemic
(that
requires
amount
drug,
expensive
risk
adverse
effects)
option,
drug
injections
often
discouraged
sight-threatening
complications
endophthalmitis.
field
encapsulation
nanoparticles,
hydrogels,
encapsulated
technology
synthesis
materials
continuously
evolving
expected
possibilities.
As
example,
implants
Ciliary
Neurotrophic
Factor
ongoing
strategies
create
expectations
future,
preferably
combinations
are,
only
disease
blindness,
indeed,
physiological
and,
opinion,
homeostasis,
determine
after
therapy
transplants.
work
was
supported
Ministerio
de
Ciencia
e
innovación
FEDER-PID2019-106230RB-I00.
Instituto
Carlos
III,
RETICS-FEDER
RD16/0008/0016.
Retina
Asturias/Cantabria.
FARPE-FUNDALUCE.
Generalitat
Valenciana
IDIFEDER/2017/064
(to
NC).
Progress in Retinal and Eye Research,
Journal Year:
2020,
Volume and Issue:
78, P. 100844 - 100844
Published: Feb. 5, 2020
This
review
summarizes
our
current
knowledge
of
primate
including
human
retina
focusing
on
bipolar,
amacrine
and
ganglion
cells
their
connectivity.
We
have
two
main
motivations
in
writing.
Firstly,
recent
progress
non-invasive
imaging
methods
to
study
retinal
diseases
mean
that
better
understanding
the
is
becoming
an
important
goal
both
for
basic
clinical
sciences.
Secondly,
genetically
modified
mice
are
increasingly
used
as
animal
models
diseases.
Thus,
it
understand
which
extent
retinas
primates
rodents
comparable.
first
compare
cell
populations
rodent
retinas,
with
emphasis
how
fovea
(despite
its
small
size)
dominates
neural
landscape
retina.
next
summarise
what
known,
not
about
postreceptoral
neurone
The
inventories
bipolar
now
nearing
completion,
comprising
~12
types
at
least
17
cell.
Primate
show
clear
differences
dendritic
field
size
across
retina,
morphology
differs
clearly
from
mouse
cells.
Compared
cells,
even
higher
morphological
diversity:
they
could
comprise
over
40
types.
Many
appear
conserved
between
mice,
but
functions
only
a
few
understood
any
or
non-primate
Amacrine
final
frontier
research
monkeys
alike.
The Journal of Comparative Neurology,
Journal Year:
2020,
Volume and Issue:
528(12), P. 2044 - 2067
Published: Jan. 31, 2020
Melanopsin
ganglion
cells
have
defied
convention
since
their
discovery
almost
20
years
ago.
In
the
following,
many
types
of
these
intrinsically
photosensitive
retinal
(ipRGCs)
emerged.
mouse
retina,
there
are
currently
six
known
(M1-M6)
melanopsin
cells,
each
with
unique
morphology,
mosaics,
connections,
physiology,
projections,
and
functions.
While
melanopsin-expressing
usually
associated
behaviors
like
circadian
photoentrainment
pupillary
light
reflex,
characterization
multiple
has
demonstrated
a
reach
that
may
extend
far
beyond
non-image-forming
vision.
fact,
studies
shown
individual
potential
to
impact
image-forming
functions
contrast
sensitivity
color
opponency.
Thus,
goal
this
review
is
summarize
morphological
functional
aspects
in
retina
highlight
respective
roles
Although
cell
do
project
brain
targets,
it
important
note
only
first
step
determining
influence
on
Even
so,
visual
system
canonically
been
divided
into
two
realms
begun
challenge
boundary
between
them,
providing
an
overlap
information
complementary
rather
than
redundant.
Further
photoreceptors
will
no
doubt
continue
illustrate
ever-expanding
role
for
Journal of Pineal Research,
Journal Year:
2021,
Volume and Issue:
70(4)
Published: March 17, 2021
Glaucoma
is
a
progressive
optic
neuropathy
associated
with
damage
to
retinal
ganglion
cells
(RGCs)
and
disrupted
circadian
rhythms.
Melatonin
promising
substance
ameliorate
glaucoma-associated
compromised
rhythms,
sleep,
mood,
function.
However,
studies
estimating
melatonin
effects
in
glaucoma
are
currently
lacking.
Therefore,
In
this
study,
we
investigated
the
effect
of
long-term
(daily
at
10:30
pm
for
90
days)
oral
administration
on
systemic
(Tb)
local
organ
vision
(IOP)
pattern
electroretinogram
(PERG),
depending
stage
patients
diagnosed
stable
or
advanced
primary
open-angle
glaucoma.
laboratory
study
15
them,
24-hour
records
salivary
were
obtained
MTNR1B
receptor
gene
polymorphism
was
assessed.
increased
stability
Tb
rhythm
by
improving
its
phase
alignment
IOP.
time-dependently
decreased
IOP
standard
deviation
(SD).
mean
SD
decreases
more
pronounced
individuals
higher
initial
mean.
improved
RGCs
function
glaucoma;
N95
amplitude
increase
correlated
positively
loss.
The
beneficial
sleep
mood
greater
Finally,
delayed
phases
observed
G-allele
carriers
Combined,
these
results
provide
evidence
efficiency
restoring
rhythms
different
vs.
indicating
that
personalized
strategy
may
further
refine
treatment
benefits.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(8), P. 4401 - 4401
Published: April 16, 2024
The
circadian
rhythms
generated
by
the
master
biological
clock
located
in
brain's
hypothalamus
influence
central
physiological
processes.
At
molecular
level,
a
core
set
of
genes
interact
to
form
transcription-translation
feedback
loops
that
provide
basis
rhythm.
In
animal
models
disease,
desynchronization
peripheral
tissues
with
has
been
detected.
Interestingly,
patients
vascular
dementia
have
sleep
disorders
and
irregular
patterns.
These
alterations
impact
hormonal
levels,
cardiovascular
health
(including
blood
pressure
regulation
vessel
function),
pattern
expression
activity
antioxidant
enzymes.
Additionally,
oxidative
stress
can
arise
from
ischemia-reperfusion
injury,
amyloid-beta
production,
abnormal
phosphorylation
tau
protein,
neurotransmitters,
among
others.
Several
signaling
pathways
are
involved
pathogenesis
dementia.
While
precise
mechanisms
linking
still
being
studied,
there
is
evidence
suggest
maintaining
healthy
patterns
supporting
proper
rhythm
function
may
be
important
for
reducing
risk
Here,
we
reviewed
main
action
targets
related
cycle
Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(6), P. 1086 - 1086
Published: May 30, 2022
Inherited
retinal
dystrophies
(IRDs)
are
a
large
group
of
genetically
and
clinically
heterogeneous
diseases
characterized
by
the
progressive
degeneration
retina,
ultimately
leading
to
loss
visual
function.
Oxidative
stress
inflammation
play
fundamental
roles
in
physiopathology
these
diseases.
Photoreceptor
cell
death
induces
an
inflammatory
state
retina.
The
activation
several
molecular
pathways
triggers
different
cellular
responses
injury,
including
microglia
eliminate
debris
recruit
cells
from
circulation.
Therapeutical
options
for
IRDs
currently
limited,
although
small
number
patients
have
been
successfully
treated
gene
therapy.
Many
other
therapeutic
strategies
being
pursued
mitigate
deleterious
effects
associated
with
oxidative
metabolism
and/or
inflammation,
inhibiting
reactive
oxygen
species’
accumulation
responses,
blocking
autophagy.
Several
compounds
tested
clinical
trials,
generating
great
expectations
their
implementation.
present
review
discusses
main
mechanisms
that
occur
latest
therapies
under
investigation.
PLoS ONE,
Journal Year:
2019,
Volume and Issue:
14(12), P. e0226197 - e0226197
Published: Dec. 10, 2019
Background
Melanopsin-expressing
retinal
ganglion
cells
(mRGCs),
intrinsically
photosensitive
RGCs,
mediate
the
light-based
pupil
response
and
light
entrainment
of
body’s
circadian
rhythms
through
their
connection
to
pretectal
nucleus
hypothalamus,
respectively.
Increased
awareness
rhythm
dysfunction
in
neurological
conditions
including
Alzheimer’s
disease
(AD),
has
led
a
wave
research
focusing
on
role
mRGCs
these
diseases.
Postmortem
analyses
AD
patients
demonstrated
significant
loss
mRGCs,
vivo
measurements
mRGC
function
with
chromatic
pupillometry
may
be
potential
biomarker
for
early
diagnosis
progression
AD.
Methods
We
performed
prospective
case-control
study
20
cognitively
healthy
participants:
10
individuals
pre-symptomatic
pathology
(pre-AD),
identified
by
presence
abnormal
levels
amyloid
β42
total
Tau
proteins
cerebrospinal
fluid,
age-matched
controls
normal
CSF
levels.
To
evaluate
function,
we
used
standardized
protocol
Ganzfeld
system
using
red
(640
nm)
blue
(450
stimuli
measured
pupillary
(PLR).
Non-invasive
wrist
actigraphy
sleep
questionnaires
were
also
completed
rest-activity
rhythm.
Results
Our
results
did
not
demonstrate
difference
PLR
between
pre-AD
but
showed
variability
group
compared
pupillometry.
Wrist
variable
sleep-wake
patterns
irregular
controls.
Conclusions
The
seen
cycle
suggests
that
occurs
stages,
preceding
cognitive
decline.
Future
longitudinal
studies
following
participants
can
help
elucidating
relationship
Neurobiology of Disease,
Journal Year:
2020,
Volume and Issue:
144, P. 105029 - 105029
Published: July 28, 2020
Circadian
organization
of
physiology
and
behavior
is
an
important
biological
process
that
allows
organisms
to
anticipate
prepare
for
daily
changes
demands.
Disruptions
in
this
system
precipitates
a
wide
range
health
issues.
In
patients
with
neurodegenerative
diseases,
alterations
circadian
rhythms
are
among
the
most
common
debilitating
symptoms.
Although
growing
awareness
these
symptoms
has
occurred
during
last
decade,
their
underlying
neuropathophysiological
circuitry
remains
poorly
understood
consequently
no
effective
therapeutic
strategies
available
alleviate
Recent
studies
have
examined
neuropathological
status
different
neural
components
governing
generation
diseases.
review,
we
will
dissect
potential
contribution
dysfunctions
nodes
A
deeper
understanding
mechanisms
provide
not
only
better
disease
neuro-pathophysiology,
but
also
hold
promise
developing
mechanisms-based
therapies.
Current Neuropharmacology,
Journal Year:
2020,
Volume and Issue:
19(2), P. 248 - 264
Published: April 29, 2020
All
mammalian
cells
exhibit
circadian
rhythm
in
cellular
metabolism
and
energetics.
Autonomous
clocks
are
modulated
by
various
pathways
that
essential
for
robust
time
keeping.
In
addition
to
the
canonical
transcriptional
translational
feedback
loop,
several
new
of
timekeeping
-
non-transcriptional
oscillations,
post-translational
modifications,
epigenetics
signaling
clock
have
been
identified.
The
physiology
is
expansive,
its
link
neurodegeneration
multifactorial.
Circadian
disruption
prevelant
contamporary
society
where
light-noise,
shift-work,
transmeridian
travel
commonplace,
also
reported
from
early
stages
Alzheimer's
disease
(AD).
alignment
bright
light
therapy
conjunction
with
chronobiotics
beneficial
treating
sundowning
syndrome
other
cognitive
symptoms
advanced
AD
patients.
We
performed
a
comprehensive
analysis
clinical
reports
review
clock,
delineate
dysfunction
AD,
unravel
dynamics
vicious
cycle
between
two
pathologies.
delineates
role
putative
targets
like
proteins
PER,
CLOCK,
BMAL1,
ROR,
clock-controlled
AVP,
SIRT1,
FOXO,
PK2
towards
future
approaches
management
AD.
Furthermore,
aging
delineated.